FRAZIER MANAGEMENT LLC - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 23 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
FRAZIER MANAGEMENT LLC ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2021$1,876,000
-58.2%
550,0000.0%0.15%
-63.7%
Q2 2021$4,483,000
-33.7%
550,0000.0%0.41%
-23.9%
Q1 2021$6,765,000
-32.6%
550,0000.0%0.54%
-29.8%
Q4 2020$10,043,000
+17.0%
550,0000.0%0.77%
+0.3%
Q3 2020$8,586,000550,0000.77%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
CHI Advisors LLC 1,379,843$11,246,0002.62%
Novo Holdings A/S 2,361,229$19,244,0000.85%
Ally Bridge Group (NY) LLC 401,747$3,274,0000.81%
SECTORAL ASSET MANAGEMENT INC 640,714$5,222,0000.42%
FRAZIER MANAGEMENT LLC 550,000$4,483,0000.41%
TFG Asset Management GP Ltd 750,000$6,113,0000.33%
Eventide Asset Management 2,485,656$19,757,0000.26%
AXA S.A. 1,111,510$9,058,0000.01%
Woodline Partners LP 25,932$211,0000.00%
WELLINGTON MANAGEMENT GROUP LLP 2,001,951$16,315,0000.00%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders